RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Peter Mundel, M.D.

Consultant, Third Rock Ventures

Email: pmundel@atlasventure.com

Dr. Peter Mundel is a past awardee of the esteemed American Society of Nephrology Young Investigator Award and a distinguished investigator leading the Mundel Laboratory at Massachusetts General Hospital and Harvard Medical School. In April 2014, Dr. Mundel, along with Dr. Anna Greka of Brigham and Women’s Hospital, received a 2014 Top 10 Clinical Research Outstanding Achievement Award from the Clinical Research Forum. In 2013, he and distinguished colleagues published the first targeted treatment for proteinuric kidney disease in the New England Journal of Medicine.

Dr. Mundel attended medical school at the University of Heidelberg in Germany. He completed a postdoctoral research fellowship in the Experimental Kidney and Circulation Research Program at the University of Heidelberg, which was funded by the German Research Foundation. He has authored and co-authored over 86 original research articles. Dr. Mundel’s focus is on the makeup and function of podocytes, key cells found in each of the one million separate filtration units packed into a single human kidney.

Selected Publications
Balbas MD, Burgess MR, Murali R, Wongvipat J, Skaggs BJ, Mundel P, Weins A, Sawyers CL. MAGI-2 scaffold protein is critical for kidney barrier function. Proc Natl Acad Sci U S A. 2014 Sep 30.

Fiorina P, Vergani A, Bassi R, Niewczas MA, Altintas MM, Pezzolesi MG, D’Addio F, Chin M, Tezza S, Ben Nasr M, Mattinzoli D, Ikehata M, Corradi D, Schumacher V, Buvall L, Yu CC, Chang JM, La Rosa S, Finzi G, Solini A, Vincenti F, Rastaldi MP, Reiser J, Krolewski AS, Mundel PH, Sayegh MH. Role of podocyte B7-1 in diabetic nephropathy. J Am Soc Nephrol. 2014 Jul; 25(7):1415-29.

Greka A, Weins A, Mundel P. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med. 2014 Mar 27; 370(13):1263-6.

Kampe K, Sieber J, Orellana JM, Mundel P, Jehle AW. Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2. Am J Physiol Renal Physiol. 2014 Feb 15; 306(4):F401-9.

Hakroush S, Cebulla A, Schaldecker T, Behr D, Mundel P, Weins A. Extensive podocyte loss triggers a rapid parietal epithelial cell response. J Am Soc Nephrol. 2014 May; 25(5):927-38.

Buvall L, Rashmi P, Lopez-Rivera E, Andreeva S, Weins A, Wallentin H, Greka A, Mundel P. Proteasomal degradation of Nck1 but not Nck2 regulates RhoA activation and actin dynamics. Nat Commun. 2013; 4:2863.

Third Rock Ventures

Related News

NEWS

NephCure Launches National Coalition to Advocate f...

JULY 27, 2023

NEWS

NephCure Patient & Youth Summit 2024 Unites Rare K...

JULY 27, 2023

NEWS

A Breakthrough in Understanding of the Cause of So...

JULY 27, 2023

NEWS

Introducing a New Destination for the Rare Kidney ...

JULY 27, 2023

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.